Cheyne Capital Management (Uk) LLP Vanda Pharmaceuticals Inc. Transaction History

Cheyne Capital Management (Uk) LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$18.25 - $23.0 $748,250 - $943,000	-41,000 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$14.05 - $20.2 $463,650 - $666,600	-33,000 Reduced 44.59%	41,000 $692,000
Q3 2017 Nov 08, 2017	BUY	$15.4 - $18.85 $770,000 - $942,500	50,000 Added 208.33%	74,000 $1.32 Million
Q3 2017 Nov 07, 2017	BUY	$15.4 - $18.85 $369,600 - $452,400	24,000	24,000 $1.32 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $279M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Cheyne Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

Stay updated on Cheyne Capital Management (Uk) LLP with notifications on news.